Progen Co., Ltd. (XKON:296160)
South Korea · Delayed Price · Currency is KRW 5,900.00
-390.00 (-6.20%)
At close: Apr 2, 2026
Progen Market Cap
Progen has a market cap or net worth of 96.71 billion as of April 1, 2026. Its market cap has increased by 24.18% in one year.
Market Cap
96.71B
Enterprise Value
n/a
Revenue
450.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
5,900.00
Market Cap Chart
Since November 15, 2023, Progen's market cap has increased from 46.33B to 96.71B, an increase of 108.76%. That is a compound annual growth rate of 36.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 96.71B | -16.58% |
| Dec 30, 2025 | 115.93B | 28.30% |
| Dec 30, 2024 | 90.36B | 9.39% |
| Dec 28, 2023 | 82.60B | 78.30% |
| Nov 15, 2023 | 46.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 120.70B |
| KoBioLabs | 115.54B |
| ViGenCell | 113.16B |
| CORESTEMCHEMON | 112.23B |
| Quratis | 102.92B |
| TegoScience | 102.32B |
| CHA Vaccine Research Institute | 100.34B |
| Cell Biotech | 98.55B |